Legacy Education (LGCY) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for December 16, 2025, and will be held virtually, allowing shareholders to vote online or by proxy in advance.
Shareholders will vote on electing six directors for a one-year term and ratifying the appointment of the independent auditor for the next fiscal year.
Proxy materials are distributed primarily via the Internet to reduce costs and environmental impact, with options for shareholders to request printed copies.
Voting matters and shareholder proposals
Shareholders will vote on the election of six board members and the ratification of LJ Soldinger Associates, LLC as the independent auditor for the fiscal year ending June 30, 2026.
Shareholder proposals for the 2026 annual meeting must be submitted by June 26, 2026, for inclusion in proxy materials.
Shareholders can submit director nominations and other proposals following specific procedures and deadlines outlined in the bylaws.
Board of directors and corporate governance
The board consists of six directors, with three considered independent under NYSE American Rules.
The board has audit, compensation, and nominating/governance committees, each with defined charters and independent members.
The chair and CEO roles are combined, with the board believing this structure is appropriate for the company's size.
Board and committee meetings are held regularly, with high attendance and independent directors meeting separately.
Director nominations consider experience, integrity, diversity, and other relevant qualifications, though there is no formal diversity policy.
Latest events from Legacy Education
- Q2 revenue up 40.7% and net income up 46%, fueled by enrollment and program expansion.LGCY
Q2 202612 Feb 2026 - Achieved 40% revenue growth and 38% enrollment increase, driven by healthcare-focused programs and acquisitions.LGCY
Investor presentation12 Feb 2026 - Revenue up 35%, net income doubled, and expansion fueled by IPO and $8M acquisition.LGCY
Q1 202514 Jan 2026 - Q2 FY2025 revenue up 29.2% with record enrollment and expanded healthcare offerings.LGCY
Q2 202516 Dec 2025 - Annual proxy details voting items and confirms standard shareholder rights.LGCY
Proxy Filing2 Dec 2025 - IPO targets $10.28M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025 - IPO seeks $10.28M to fund growth, with strong financials but high regulatory exposure.LGCY
Registration Filing29 Nov 2025 - IPO seeks up to $11.95M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025 - Strong growth in revenue and enrollment, with IPO funding expansion amid regulatory risks.LGCY
Registration Filing29 Nov 2025